EBOS Group Limited

DB:EJG Stock Report

Market Cap: €2.2b

EBOS Group Valuation

Is EJG undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of EJG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: EJG (€10.2) is trading below our estimate of future cash flow value (€32.82)

Significantly Below Future Cash Flow Value: EJG is trading below future cash flow value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for EJG?

Key metric: As EJG is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for EJG. This is calculated by dividing EJG's market cap by their current earnings.
What is EJG's PE Ratio?
PE Ratio15.7x
EarningsAU$229.47m
Market CapAU$3.60b

Price to Earnings Ratio vs Peers

How does EJG's PE Ratio compare to its peers?

The above table shows the PE ratio for EJG vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average19.3x
ILM1 Medios
21.1x27.17%€324.9m
AFX Carl Zeiss Meditec
19.5x19.33%€2.4b
RHK RHÖN-KLINIKUM
23.9x17.73%€823.3m
DRW3 Drägerwerk KGaA
12.5x4.53%€1.5b
EJG EBOS Group
15.7x8.58%€4.4b

Price-To-Earnings vs Peers: EJG is good value based on its Price-To-Earnings Ratio (15.7x) compared to the peer average (19.3x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does EJG's PE Ratio compare vs other companies in the European Healthcare Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
EJG 15.7xIndustry Avg. 18.8xNo. of Companies10PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: EJG is good value based on its Price-To-Earnings Ratio (15.7x) compared to the European Healthcare industry average (19.1x).

Price to Earnings Ratio vs Fair Ratio

What is EJG's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

EJG PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio15.7x
Fair PE Ratio19.1x

Price-To-Earnings vs Fair Ratio: EJG is good value based on its Price-To-Earnings Ratio (15.7x) compared to the estimated Fair Price-To-Earnings Ratio (19.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst EJG forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€10.20
€17.02
+66.84%
12.94%€19.61€11.89n/a8
Apr ’27€10.50
€17.29
+64.63%
13.44%€20.15€11.93n/a8
Mar ’27€11.70
€17.02
+45.47%
13.42%€19.78€11.71n/a8
Feb ’27€12.60
€17.50
+38.92%
16.28%€20.58€11.41n/a8
Jan ’27€12.90
€18.25
+41.43%
9.51%€20.24€14.79n/a8
Dec ’26€13.50
€18.26
+35.29%
8.39%€20.14€15.75n/a8
Nov ’26€13.90
€18.48
+32.95%
8.24%€20.29€15.86n/a8
Oct ’26€14.50
€18.27
+26.00%
8.28%€20.04€15.67n/a8
Sep ’26€19.30
€19.11
-1.00%
7.63%€21.13€16.11n/a9
Aug ’26€20.00
€20.82
+4.09%
10.86%€23.56€16.39n/a8
Jul ’26€19.60
€20.69
+5.55%
10.71%€23.51€16.36n/a8
Jun ’26€19.00
€20.55
+8.13%
10.76%€23.40€16.24n/a8
May ’26€18.70
€20.55
+9.87%
10.76%€23.40€16.24n/a8
Apr ’26€19.60
€21.96
+12.06%
10.59%€24.62€17.27€10.508
Mar ’26€20.20
€21.96
+8.73%
10.59%€24.62€17.27€11.708
Feb ’26€21.20
€21.28
+0.38%
9.54%€24.33€17.02€12.608
Jan ’26€20.00
€20.83
+4.17%
7.86%€22.67€17.06€12.908
Dec ’25€20.80
€21.45
+3.13%
7.66%€23.28€17.73€13.508
Nov ’25€19.30
€21.45
+11.14%
7.66%€23.28€17.73€13.908
Oct ’25€20.20
€21.28
+5.35%
7.79%€23.26€17.57€14.508
Sep ’25€19.30
€21.06
+9.13%
7.79%€23.02€17.39€19.308
Aug ’25€19.30
€20.88
+8.17%
9.14%€23.28€17.09€20.008
Jul ’25n/a
€21.85
0%
8.52%€24.01€17.63€19.608
Jun ’25€19.50
€21.51
+10.32%
8.66%€23.54€17.20€19.008
May ’25n/a
€21.47
0%
8.92%€23.45€17.14€18.708
Apr ’25€19.50
€21.27
+9.10%
8.87%€23.16€16.92€19.608
€16.22
Fair Value
37.1% undervalued intrinsic discount
8
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/23 14:42
End of Day Share Price 2026/04/23 00:00
Earnings2025/12/31
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

EBOS Group Limited is covered by 17 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Benjamin BrayshawBarrenjoey Markets Pty Limited
Saul HadassinBarrenjoey Markets Pty Limited
Lyanne HarrisonBofA Global Research